Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.43)
# 2,499
Out of 5,131 analysts
135
Total ratings
51.19%
Success rate
-0.97%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Upgrades: Outperform | $14 → $25 | $17.39 | +43.76% | 11 | Jan 6, 2026 | |
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $23.03 | +30.26% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $15.41 | +81.70% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $43.79 | +59.85% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $77.64 | +15.92% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $201.11 | +9.39% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.46 | +7.24% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $80.30 | +18.31% | 10 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $172.79 | -1.61% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $12.78 | +1.72% | 8 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $220 → $240 | $242.41 | -0.99% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $47.92 | +35.64% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.48 | +20.97% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $174.44 | +8.92% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $251.81 | +21.12% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $816.06 | +1.10% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $23.63 | -2.67% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.99 | +202.39% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $34.50 | +4.35% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $2.38 | +1,002.94% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $4.00 | +275.00% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.40 | +685.71% | 2 | Jan 4, 2022 |
Fortrea Holdings
Jan 6, 2026
Upgrades: Outperform
Price Target: $14 → $25
Current: $17.39
Upside: +43.76%
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $23.03
Upside: +30.26%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $15.41
Upside: +81.70%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $43.79
Upside: +59.85%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $77.64
Upside: +15.92%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $201.11
Upside: +9.39%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.46
Upside: +7.24%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $80.30
Upside: +18.31%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $172.79
Upside: -1.61%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $12.78
Upside: +1.72%
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $242.41
Upside: -0.99%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $47.92
Upside: +35.64%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.48
Upside: +20.97%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $174.44
Upside: +8.92%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $251.81
Upside: +21.12%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $816.06
Upside: +1.10%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $23.63
Upside: -2.67%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.99
Upside: +202.39%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $34.50
Upside: +4.35%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $2.38
Upside: +1,002.94%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.00
Upside: +275.00%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.40
Upside: +685.71%